Library / Laws / 115th Congress / House Bills / H.R. 1223
H.R. 1223
To amend the Federal Food, Drug, and Cosmetic Act to authorize an extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-02-27 | 7.3K | ⠃⠗⠋ |